HDAC11 and metabolic disease: Due to the unique connection of HDAC11 with several pathophysiologicalconditions, HDAC11-selective inhibitors are highly desirable and envisionedto have unique therapeutic potential, for example, for treatment ofcancer and metabolic diseases.